Key result
Remote behavioral interventions boost medication adherence by ~70% and improve SBP and HbA1c.
Why the study?
Nearly half of patients with cardiometabolic conditions do not take medication as prescribed, and the effectiveness of remote behavioral interventions to improve adherence needed evaluation.
Do remote behavioral interventions improve medication adherence and clinical indicators in patients with cardiometabolic conditions?
Meta-Analysis (n=24,672)
Do remote behavioral interventions improve medication adherence and clinical indicators in patients with cardiometabolic conditions?
Odds Ratio: 1.7 (95% CI 1.47–1.96)
p-value: p=< .001
Remote behavioral interventions facilitated by healthcare providers effectively improve medication adherence and clinical indicators like blood pressure, HbA1c, and LDL in patients with cardiometabolic conditions.
Supports integrating remote behavioral interventions into cardiometabolic care to improve adherence; extends evidence base despite low study quality.
BACKGROUND: Although cardiometabolic conditions account for over 32% of all global deaths, nearly half of the patients with cardiometabolic conditions do not take medication as prescribed. Remote behavioral interventions have been shown to potentially improve adherence in these patients and further support cost effective clinical practice. PURPOSE: To evaluate the effectiveness of remote behavioral interventions at improving treatment adherence and to explore behavioral intervention components associated with it. METHODS: We searched MEDLINE, EMBASE, PsycINFO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science in April 2021. Random-effects meta-analyses were utilized. RESULTS: In total, 40 studies, including 24,672 participants, were included. The overall quality of evidence, assessed using the RoB2 tool, was low. The intervention had a small (odds ratios [OR] = 1.70, 95% CI: 1.47, 1.96, N = 4823 p < .001) to moderate effect (SMD = 0.57, 95% CI: 0.38, 0.76, N = 20,271, p < .001) on the dichotomous and continuous outcomes, respectively. Systolic blood pressure (SBP) was reduced by 3.71 mmHg (95% CI: 3.99, 3.43, N = 6,527, p < .001) and participants receiving the intervention were twice more likely to achieve blood pressure (BP) control (OR = 2.14, 95% CI: 1.61, 2.84, N = 1,172, p < .001). Generally, HBA1c decreased by 0.25% (95% CI: 0.33, 0.17, N = 6,734, p < .001), whereas low-density lipoprotein (LDL)-cholesterol dropped by 6.82 mg/dL (95% CI: 8.33, 5.30, N = 4,550, p < .001) in favor of the intervention. There was a trend suggesting a potential positive effects on reducing visits to emergency department (OR=0.76, 95% CI: 0.57, 1.01, N = 4,182) and mortality rates (OR=0.78, 95% CI: 0.42, 1.42, N = 1,971), and no risk for hospital readmission (OR=1.00, 95% CI: 0.83, 1.20, N = 5,402), favoring the intervention. CONCLUSIONS: Despite low quality of evidence, remote consultations are effective at improving medication adherence and clinical indicators, and potentially cost-effective solution for health care services.
No takes yet. Share an insight, caveat, or question.
Chilala et al. (2022) conducted a meta-analysis in cardiometabolic conditions (n=24,672). Remote behavioral interventions was evaluated on medication adherence (dichotomous outcomes) (OR 1.70, 95% CI 1.47, 1.96, p=< .001). Remote behavioral interventions significantly improved medication adherence (OR 1.70; 95% CI 1.47-1.96; p<0.001) and clinical indicators like systolic blood pressure and HbA1c.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: